Moderna

Cathie Wood's Wednesday Exodus: Moderna And Jack Dorsey's Block Stocks Get Dumped
Cathie Wood Continues To Sell Shares Of Jack Dorsey's Bitcoin-Focused Company Block — Ark Also Dumps Moderna, Robinhood Stock
Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table
Cathie Wood Continues To Sell Shares Of Jack Dorsey's Bitcoin-Focused Company Block — Ark Also Dumps Moderna, Robinhood Stock
Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table
Amid Rapidly Rising Bird Flu Cases, Moderna Lands $176M Worth US Government Contract For Vaccine
Cathie Wood-Led Ark Invest Cuts Robinhood Holdings Amid Bitcoin Dip, Keeps Selling Moderna Stock — Buys Palantir And AMD Shares

Moderna Recent News

Costco, Pfizer, Moderna, Lennar Corp, Tesla: Why These 5 Stocks Are On Investors' Radars Today
The stock market witnessed a notable surge today, with the Dow Jones rising 0.43% to 37,248.35 and the S&P 500 gaining 0.26% to 4,719.55.
Cathie Wood's Ark Invest Goes Shopping For Moderna Stock — Sells DraftKings Shares Amid Quarterly Rise In Revenue, EPS Beat
Nvidia, United Airlines, Moderna, Lucid, Bank Of America: Why These Five Stocks Are On Investors' Horizons Today
U.S. stocks exhibited a mixed performance as the trading day drew to a close, with the Nasdaq Composite taking a dip of around 30 points.
Nvidia, Zoom, Moderna, Baidu, Tesla: Why These Five Stocks Are Drawing Investors' Attention Today
Cathie Wood's Ark Buy More Moderna Shares As It Trims Stake In This Warren Buffett-Backed EV Maker
$1 Billion Deal For Moderna To Expand Product Pipeline In China
The defensive stocks sector has been underperforming most - if not all - of the remaining cyclical sectors in the U.S. economy. These preferences come from underlying dynamics in the money markets and where investors think we are in the business cycle.
Pharma Giants Moderna And Novavax Trend Lower In This Pattern: What's Going On?
Moderna Inc. (NASDAQ: MRNA) and Novavax Inc. (NASDAQ: NVAX) were trading down over 2% and 4%, respectively in the premarket Friday despite both stocks showing signs a bounce could be in the cards.
8 S&P 500 Stocks Up More Than 100% In 2021
The year 2021 has featured retail trading-induced short squeezes, soaring special purpose acquisition companies (SPACs) and extreme volatility in cryptocurrency markets. Amid the many bouts of short-term mania, there are a handful of stocks in the S&P 500 Index that have more than doubled this year. 
Moderna Boosters Might Not Be Ready By Sept 20, Pfizer On Track: Fauci
On Sunday, President Joe Biden's Chief Medical Adviser Dr. Anthony Fauci said officials would soon get the regulatory clearance to administer Covid-19 vaccine booster shots made by Pfizer Inc (NYSE: PFE).
The Latest Barron's Picks And Pans: Facebook, Jefferies, Palantir, Spotify And More
This weekend's Barron's cover story examines the long-term prospects for big tech companies currently in the sights of regulators and lawmakers.
Why Former NYSE Trader Bought Moderna, Sofi, Sonos and Coinbase Stock On Monday Morning
Veteran trader David Green was back live trading on Benzinga Monday morning, and the long-time trader made some moves. 
Moderna's Shot Seems To Have A Better Shot Against Delta Than Pfizer's
Besides proudly stating that its Covid-19 shot produced a "robust" antibody response against the highly contagious delta variant last Thursday, Moderna (NASDAQ: MRNA) also posted second-quarter financial results that beat Wall Street's expectations on both earnings and revenue.
Sponsored
Could August Become 7th Straight Month Of Gains? Busy Week Could Set The Tone
And so begins the month of August. The dog days of summer. Beaches, mountains, and lazy afternoons.If you follow the financial markets, that thinking might be jumping the gun, as there’s still plenty of action ahead.
Sponsored
The Vaccine Club- Fall Will Be The Ultimate Test
Sponsored
Benzinga's Bulls And Bears Of The Week: Apple, Coca-Cola, GM, Moderna, Tesla And More
Benzinga has examined the prospects for many investor favorite stocks over the past week. Last week's bullish calls included the iPhone maker and top automakers. Bank stocks, a vaccine maker and a leading miner were among the bearish calls seen.
Benzinga's Bulls And Bears Of The Week: Apple, Amazon, Biogen, Bitcoin, Tesla And More
Benzinga has examined the prospects for many investor favorite stocks over the past week. The past week's bullish calls included the e-commerce leader, a top biotech and the airlines.
Uber, Moderna Lose Ground After Both Companies Miss Analysts' Revenue Estimates
It’s been more than a week since Technology finished in the green. Tech stocks rose in pre-market trading, but can they maintain those early gains? That’s one question hanging over Wall Street today.  We’ll talk more about the trauma in Tech lower down. First, let’s take care of some data and earnings business. 
Barron's Latest Picks And Pans: Moderna, Netflix, Perrigo, XPO Logistics And More
This weekend's Barron's cover story presents the results of the latest Barron's Big Money Poll. Other featured articles show which food stocks are worth bite and which real estate stocks have room to run.
FDA, CDC Officials Discuss Johnson & Johnson Vaccine: A 'Pause Recommendation', Resolution Timeline And Advisory
The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) handed down a recommendation to pause the use of Johnson & Johnson's (NYSE:
Barron's Latest Picks And Pans: Bank Stocks, BDCs, Blackstone, Fluor, Oracle And More
This weekend's Barron's cover story explores one enterprise software company's transformation into a cloud giant. Other featured articles discuss who dominates the public cloud, who stands to benefit as Texas rebuilds and how to tell when tech companies are overvalued.
Benzinga's Bulls And Bears Of The Week: Amazon, Comcast, GE, Moderna, Tesla And More
Benzinga has examined the prospects for many investor favorite stocks over the past week. The week's bullish calls included the e-commerce, electric vehicle and online sports betting leaders.
February Outlook: Six Things To Look For Include Fed Testimony, Vaccine Progress, Big-Box Earnings
The groundhog is about to tell us how much longer winter might last. At the same time, events in February could give investors an idea how much longer COVID-19 might keep the economy’s emergency brake pressed to the floor.
Fintech Focus For January 27, 2021

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved